N-trans-Feruloyloctopamine Wakes Up BBC3, DDIT3, CDKN1A, and NOXA Signals to Accelerate HCC Cell Apoptosis

N-trans-Feruloyloctopamine (FO), a natural compound, was reported in our previous study to inhibit a tumor cell malignant phenotype by AKT- and EMT-related signals and might be used as a promising drug for HCC treatment. However, the specific targets and detailed mechanisms still need to be clarifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bin, Li, Jing, Yang, Wen-Ke, Zhang, Mei-Gui, Xie, Xiao-Dong, Bai, Zhong-Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166497/
https://www.ncbi.nlm.nih.gov/pubmed/34123711
http://dx.doi.org/10.1155/2021/1560307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166497/
https://www.ncbi.nlm.nih.gov/pubmed/34123711
http://dx.doi.org/10.1155/2021/1560307

Ejemplares similares